HI
COCHW icon

HBK Investments’s Envoy Medical Warrant COCHW Stock Holding History

HBK Investments’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-125,599
Closed -$80K – 738
2021
Q3 		$80K Sell
125,599
-10,701
-8% -$8.7K ﹤0.01% 640
2021
Q2 		$131K Buy
+136,300
New +$97.2K ﹤0.01% 706

Other funds holding COCHW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

HBK Investments's COCHW Position: Q2 2022 in Review

HBK Investments sold out of Envoy Medical Warrant (COCHW) in Q2 2022, closing a stake of 69,000 shares — an estimated $17K sold.

HBK Investments first reported a position in COCHW in Q4 2021 and held it in 2 quarters. The position peaked at $59K in Q4 2021. 56 funds tracked by Wall St. Rank hold COCHW as of Q2 2022.

  • HBK Investments reported no remaining Envoy Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 69,000 Envoy Medical Warrant shares in Q2 2022, an estimated $17K.
  • HBK Investments first reported a position in Envoy Medical Warrant in Q4 2021 and held it in 2 quarters.
  • HBK Investments's Envoy Medical Warrant position peaked at $59K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.